Skip to NavigationSkip to content

News

AbbVie has made it known that Skyrizi (risankizumab) came out on top versus Novartis’ Cosentyx (secukinumab) at Phase 3 in the treatment of plaque...
Public Health England has released figures that show that HIV rates in bi and gay men have fallen by 73% since 2014 in the UK.
NICE has chosen to reject MSD’s blockbuster immunotherapy Keytruda for routine use on the NHS as a treatment for metastatic or unresectable...
It has been announced that the FDA has moved to approve Lannett Company’s Numbrino (cocaine hydrochloride) nasal solution.
FDA unanimously voted against Nektar Therapeutics opioid pankiller (NKTR-181) for chronic lower back pain, prompting the company to withdraw its...
NICE, the drug watchdog for England and Wales, has given its approval for Pfizer’s Ibrance (palbociclib) in combination with AstraZeneca’s Faslodex...
The Rochester Drug Cooperative (RDC) has announced it will no longer distribute opioid medications, after two of its executives were charged with...
Two presidential candidates said that if they are elected President they will act immediately to reduce the cost of certain drugs, with or without...
The recent viral pneumonia outbreak in Wuhan China has spread to Thailand, in a woman who has travelled from the region to the country.
MorphoSys and Incyte have joined together in a partnership to develop and commercialise the latter’s anti-CD19 antibody tafasitamab as a treatment...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches